Market Tracker

09/22 5:16pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

23.45
Delayed Data
As of Sep 22
 -0.15 / -0.64%
Today’s Change
13.60
Today|||52-Week Range
33.00
+24.73%
Year-to-Date
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close23.60
Today’s open23.55
Day’s range23.15 - 23.70
Volume316,739
Average volume (3 months)858,487
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+528.00%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp-0.11-0.52%
ATNXAthenex Inc-0.64-3.66%
DERMDermira Inc-0.32-1.20%
CLLSCellectis SA-0.14-0.50%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.62
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Scientific Officer
Andrew R. Blight
Corporate headquarters
Ardsley, New York

Forecasts